Health & Fitness
Mon, January 30, 2012Sat, January 28, 2012Fri, January 27, 2012Thu, January 26, 2012Wed, January 25, 2012Tue, January 24, 2012Mon, January 23, 2012Sun, January 22, 2012Sat, January 21, 2012Fri, January 20, 2012Thu, January 19, 2012Wed, January 18, 2012Amgen Announces Webcast of 2011 Fourth Quarter and Full Year Financial Results
Published in Health and Fitness on Tuesday, January 24th 2012 at 13:18 GMT by Market Wire
Amgen Announces Webcast of 2011 Fourth Quarter and Full Year Financial... -- THOUSAND OAKS, Calif., Jan. 24, 2012 /PRNewswire/ --
Amgen Announces Webcast of 2011 Fourth Quarter and Full Year Financial Results
THOUSAND OAKS, Calif., Jan. 24, 2012 /PRNewswire/ -- Amgen (NASDAQ: [ AMGN ]) today announced that it will report its fourth quarter and full year 2011 financial results on Thursday, Jan. 26, 2012 after the close of the financial markets. The announcement will be followed by a conference call with the investment community at 2:00 p.m. Pacific Standard Time. Participating in the call from Amgen will be Kevin Sharer, chairman and chief executive officer, and other members of Amgen's senior management team.
Live audio of the conference call will be simultaneously broadcast over the Internet and will be available to members of the news media, investors and the general public.
The webcast of the conference, as with other selected presentations regarding developments in Amgen's business given by management at certain investor and medical conferences, can be found on Amgen's website, [ www.amgen.com ], under Investors. Information regarding presentation times, webcast availability and webcast links are noted on Amgen's Investor Relations Events Calendar.
About Amgen
Amgen discovers, develops, manufactures and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science's promise by bringing safe, effective medicines from lab to manufacturing plant to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, bone disease and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives. To learn more about our pioneering science and vital medicines, visit [ www.amgen.com ]. Follow us on [ www.twitter.com/amgen ].
CONTACT: Amgen, Thousand Oaks
Christine Regan, 805-447-5476 (media)
Arvind Sood, 805-447-1060 (investors)
(Logo: [ http://photos.prnewswire.com/prnh/20081015/AMGENLOGO ])
SOURCE Amgen
[ Back to top ] RELATED LINKS
[ http://www.amgen.com ]
